Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Kalorama Reports | Drug Delivery Markets: Implantable - Injectable and Needle-Free Delivery Systems

Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

Needle-free drug delivery
Other Injectable/Implantable

Kalorama's unique analysis offers segmentation of this market for:

Drug Delivery Technology Revenues
Pharmaceuticals Sold via Delivery Technology

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)

The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

Detailed Profiles of Key Companies in Implantable/Injectable Delivery
Brief Round-Up of Smaller Players
Current Market Size and Forecasts to 2013
Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments
Revenue Forecasts
New Products in Development

Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Companies Profiled in the report include:

Alkermes, Inc.
ALZA Corp.
Antares Pharma, Inc.
Bioject Medical Technologies, Inc.
CyDex, Inc.
MGI Pharma, Inc
Nektar Therapeutics
Pacira Pharmaceuticals, Inc.
pSivida
SurModics, Inc
Zogenix Corporation
AP Pharma
Baxter BioPharma Solutions
QLT USA, Inc
Ypsomed Holding AG

Sep 1, 2009
110 Pages - Pub ID: KLI2422083

Table of Contents

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions